5-Methyl-MDA
Chemical compound
From Wikipedia, the free encyclopedia
5-Methyl-MDA, also known as 5-methyl-3,4-methylenedioxyamphetamine, is an entactogen and psychedelic designer drug of the amphetamine class. It is a ring-methylated homologue of MDA and a structural isomer of MDMA.[1]
- None
- CA: Schedule I
- DE: NpSG (Industrial and scientific use only)
- UK: Class A
- US: Unscheduled
- 749191-14-8
204916-89-2 (HCl)
 | |
| Clinical data | |
|---|---|
| Routes of administration | Oral |
| ATC code |
|
| Legal status | |
| Legal status |
|
| Identifiers | |
| |
| CAS Number |
|
| PubChem CID | |
| ChemSpider | |
| UNII | |
| ChEMBL | |
| CompTox Dashboard (EPA) | |
| Chemical and physical data | |
| Formula | C11H15NO2 |
| Molar mass | 193.246 g·mol−1 |
| 3D model (JSmol) | |
| |
| |
  (what is this?) (verify) | |
Pharmacology
5-Methyl-MDA acts as a selective serotonin releasing agent (SSRA) with IC50 values of 107nM, 11,600nM, and 1,494nM for serotonin, dopamine, and norepinephrine release, respectively.[1]
2-methyl-MDA and 5-methyl-MDA have been used to help guide computer modelling of the serotonin transporter complex.[2]
Society and culture
Legal status
International
5-Methyl-MDA is not scheduled by the United Nations' Convention on Psychotropic Substances.[3]
Canada
As per the Safe Streets and Communities Act, 5-methyl-MDA, along with all other amphetamines, is a Schedule I controlled substance under the Controlled Drugs and Substances Act.
United States
5-Methyl-MDA is not explicitly scheduled at the federal level in the United States,[4] however 5-Methyl-MDA is a structural isomer of MDMA, and so sales or possession could potentially be prosecuted under the Federal Analogue Act.[5]